BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22563277)

  • 1. Eosinophilic otitis media: CT and MRI findings and literature review.
    Chung WJ; Lee JH; Lim HK; Yoon TH; Cho KJ; Baek JH
    Korean J Radiol; 2012; 13(3):363-7. PubMed ID: 22563277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
    Iino Y
    Auris Nasus Larynx; 2023 Aug; 50(4):479-489. PubMed ID: 36528403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochlear implantation in a patient with eosinophilic otitis media.
    Iwasaki S; Nagura M; Mizuta K
    Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):365-9. PubMed ID: 16328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y; Takahashi E; Ida S; Kikuchi S
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of eosinophilic otitis media: a systematic review.
    Chen T; Ashman PE; Bojrab DI; Johnson AP; Hong RS; Benson B; Svider PF
    Acta Otolaryngol; 2021 Jun; 141(6):579-587. PubMed ID: 33825596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into Eosinophilic Otitis Media.
    Kanazawa H; Yoshida N; Iino Y
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of IL-5 Inhibitor Benralizumab as a Novel Therapy for Eosinophilic Otitis Media: Clinical Capsule and Review of Literature.
    Chow K; Cosetti MK
    Otol Neurotol; 2020 Feb; 41(2):e238-e240. PubMed ID: 31923159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
    Esu Y; Masuda M; Yoshida N
    Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IgE in eosinophilic otitis media.
    Iino Y
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report.
    van der Lans RJL; van Spronsen E; Fokkens WJ; Reitsma S
    Laryngoscope; 2021 Dec; 131(12):2649-2651. PubMed ID: 34216146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical diagnosis and treatment of eosinophilic otitis media].
    Zhang YZ; Wei XY; Chen ZC; Sun M; Cheng Y; Gao Y; Chen FY; Hu J; Xu M; Zhang Q; Fan MY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):160-163. PubMed ID: 30808144
    [No Abstract]   [Full Text] [Related]  

  • 16. Eosinophilic otitis media is associated with asthma severity and smoking history.
    Seo Y; Nonaka M; Tagaya E; Tamaoki J; Yoshihara T
    ORL J Otorhinolaryngol Relat Spec; 2015; 77(1):1-9. PubMed ID: 25633710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Sekine Y; Yoshida S; Kikuchi S
    Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomical Features Around Eustachian Tube in Eosinophilic Otitis Media With Eosinophilic Sinusitis.
    Ohira S; Komori M; Matsui H; Furuya H; Kajiwara R; Matsuura K; Wada K
    Laryngoscope; 2021 Oct; 131(10):E2689-E2695. PubMed ID: 34060671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eosinophilic otitis media].
    de Jong MA; Smithuis LO; Stokroos RJ
    Ned Tijdschr Geneeskd; 2014; 158():A8044. PubMed ID: 25387983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.